Rhythm Pharmaceuticals Coverage Assumed by Leerink Partners at Outperform
Ratings actions GMT) Rhythm Pharmaceuticals Price Target Announced at $133.00/Share by Leerink PartnersRatings actions
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.